Regeneron Pharmaceuticals (45) | Business Operations (3)
Browse by Subcategory
Third Amendment to Amended and Restated License and Collaboration Agreement, dated as of April 5, 2020, and effective as of April 1, 2020, by and between the Registrant, Sanofi...
(Filed With SEC on August 5, 2020)
Amended and Restated Immuno-oncology Discovery and Development Agreement, executed on January 2, 2019 and effective as of December 31, 2018, by and between the Registrant and...
(Filed With SEC on February 7, 2019)
Form of Co-Co Collaboration Agreement (Exhibit B to Master Agreement contained in Exhibit 10.4)
(Filed With SEC on August 6, 2019)